Medical News |
- Attributional behavior warns of mood transition
- Attributional behavior warns of mood transition
- Subclinical psychosis rarely troublesome
- DOSE excels in predicting COPD exacerbations
- Subclinical psychosis rarely troublesome
- Exophytic RCC lesions predict benign histology
- Poor evidence occludes locally advanced RCC surgery recommendations
- Best sequence for optimal targeted mRCC therapy remains elusive
| Attributional behavior warns of mood transition Posted: 26 Jun 2013 05:00 PM PDT A tendency to make extreme attributions may forewarn of a change of mood in patients in a depressive bipolar episode, research suggests. |
| Attributional behavior warns of mood transition Posted: 26 Jun 2013 05:00 PM PDT A tendency to make extreme attributions may forewarn of a change of mood in patients in a depressive bipolar episode, research suggests. |
| Subclinical psychosis rarely troublesome Posted: 26 Jun 2013 05:00 PM PDT Subclinical psychotic symptoms are quite common in the general population, but rarely cause distress, a study shows. |
| DOSE excels in predicting COPD exacerbations Posted: 26 Jun 2013 05:00 PM PDT Research shows that the DOSE index outperforms both the BODE and ADO indices in predicting future exacerbations of chronic obstructive pulmonary disease in Japanese patients. |
| Subclinical psychosis rarely troublesome Posted: 26 Jun 2013 05:00 PM PDT Subclinical psychotic symptoms are quite common in the general population, but rarely cause distress, a study shows. |
| Exophytic RCC lesions predict benign histology Posted: 25 Jun 2013 05:00 PM PDT Age, gender, and exophytic properties may help clinicians predict benign histology in patients with T1a renal cell carcinomas, suggest findings published in the International Journal of Urology. |
| Poor evidence occludes locally advanced RCC surgery recommendations Posted: 25 Jun 2013 05:00 PM PDT Researchers have failed to find sufficient evidence to conclude whether concomitant lymph node dissection or ipsilateral adrenalectomy with radical nephrectomy improves oncologic outcomes for patients with locally advanced renal cell carcinoma. |
| Best sequence for optimal targeted mRCC therapy remains elusive Posted: 25 Jun 2013 05:00 PM PDT The use of targeted therapies for metastatic renal cell carcinoma could see patients surviving in excess of 2 years, suggest findings from the Institut Gustave Roussy in Paris, France. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment